menu
    • menu

    Company profile for Oragenics

    NEW Drugs in Dev: 7
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oragenics is focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics, Inc. has established two exclusive worldwide channel collaborations with Intrexon Corporation Inc., a synthetic biology company. The collaborations allow Oragenics access to Intrexon's proprietary technologies toward the goal of accelerating the development of much need...
    Oragenics is focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics, Inc. has established two exclusive worldwide channel collaborations with Intrexon Corporation Inc., a synthetic biology company. The collaborations allow Oragenics access to Intrexon's proprietary technologies toward the goal of accelerating the development of much needed new antibiotics that can work against resistant strains of bacteria and the development of biotherapeutics for oral mucositis and other diseases

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OragenicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4902 Eisenhower Blvd. Suite 125 Tampa, FL 33634
    Telephone
    Telephone
    813-286-7900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oragenics.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/oragenics-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oragenics Advances Clinical-Stage Therapy For Concussion,
    Oragenics Advances Clinical-Stage Therapy For Concussion,

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234525/0/en/Oragenics-Targets-Projected-9-Billion-Market-by-Advancing-First-and-Only-Clinical-Stage-Concussion-and-Mild-Traumatic-Brain-Injury-Therapy.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Oragenics to Participate in SCOPE Summit 2026
    Oragenics to Participate in SCOPE Summit 2026

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230275/0/en/Oragenics-to-Participate-in-SCOPE-Summit-2026-Focused-on-Advancing-Clinical-Research-and-Patient-Care.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share
    Oragenics Presents at 2026 Sequire Summit in Puerto Rico
    Oragenics Presents at 2026 Sequire Summit in Puerto Rico

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3218640/0/en/Oragenics-to-Present-at-the-2026-Sequire-Investor-Summit-in-Puerto-Rico.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    Oragenics Resolves NYSE American Compliance, Fixes Stockholder
    Oragenics Resolves NYSE American Compliance, Fixes Stockholder

    21 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-21/oragenics-regains-full-nyse-american-compliance-company-resolves-stockholder-equity-deficiency

    PHARMIWEB
    21 Oct 2025
    Share Share
    Oragenics Partners With Receptor.Ai To Speed Up Development
    Oragenics Partners With Receptor.Ai To Speed Up Development

    07 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-07/oragenics-announces-strategic-partnership-with-receptorai-to-accelerate-pipeline-development

    PHARMIWEB
    07 Oct 2025
    Share Share
    Oragenics Q2 2025 Shareholder News
    Oragenics Q2 2025 Shareholder News

    11 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/11/3130934/0/en/Oragenics-Q2-2025-Shareholder-Update.html

    GLOBENEWSWIRE
    11 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search